Tag: cardiomyopathy
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Diabetes Drug Dapagliflozin Cuts Heart Failure Risk by 32% in Genetically Vulnerable Patients
New research shows dapagliflozin reduces heart failure risk by 32% in patients with cardiomyopathy-associated genetic variants. The study from Mass…
Submit Your Paper to GMJ
No APC until January 2027.